Journal article
Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice.
Abstract
INTRODUCTION: Intermittent androgen deprivation therapy (IADT) for prostate cancer involves cycles of androgen deprivation therapy (ADT) with a period between cycles where testosterone is allowed to rise above castrate levels. A number of recent randomized controlled trials (RCTs) have compared survival and health-related quality-of-life (HRQOL) between IADT and continuous ADT (CADT). This review seeks to critically analyze these published …
Authors
Dason S; Allard CB; Wang JG; Hoogenes J; Shayegan B
Journal
Canadian Journal of Urology, Vol. 21, No. 2 Supp 1, pp. 28–36
Publication Date
April 2014
ISSN
1195-9479